2024 biotech funding tracker: recent highlights
…August 2024: MeiraGTx (United States/United Kingdom): $50 million offering | genetic medicines | phase 2 in xerostomia TC BioPharm (United Kingdom): $2 million registered direct offering | T cell therapies…